Atopic dermatitis and vitiligo are very different disease states clinically. How is it that topical ruxolitinib cream shows efficacy in both of them?

Featuring James Del Rosso, DO | Clinical Advisor | Adjunct Clinical Professor (Dermatology) Touro University Nevada Henderson, NV Research Director/ Principal Investigator/ Clinical Dermatologist JDR Dermatology Research Las Vegas, NV | Published April 28, 2022